Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
47
ANGO Quote, Financials, Valuation and Earnings
Last price:
$11.21
Seasonality move
:
-5.75%
Day range:
$11.07 - $11.36
52-week range:
$8.27 - $13.99
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.50x
P/B ratio:
2.62x
Volume:
227.2K
Avg. volume:
591.3K
1-year change:
5.95%
Market cap:
$462.5M
Revenue:
$292.5M
EPS (TTM):
-$0.67
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ANGO
AngioDynamics, Inc.
|
$76.4M | -$0.10 | 6.62% | -1.95% | $19.33 |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.3% | 75.74% | $104.75 |
|
ISRG
Intuitive Surgical, Inc.
|
$2.8B | $2.27 | 16.31% | 10.87% | $611.82 |
|
MASI
Masimo Corp.
|
$408.3M | $1.47 | 7.02% | 565.51% | $178.60 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ANGO
AngioDynamics, Inc.
|
$11.22 | $19.33 | $462.5M | -- | $0.00 | 0% | 1.50x |
|
ABT
Abbott Laboratories
|
$112.21 | $133.39 | $195.1B | 30.19x | $0.63 | 2.14% | 4.43x |
|
BSX
Boston Scientific Corp.
|
$74.58 | $104.75 | $110.6B | 38.46x | $0.00 | 0% | 5.55x |
|
ISRG
Intuitive Surgical, Inc.
|
$504.05 | $611.82 | $179B | 64.00x | $0.00 | 0% | 18.17x |
|
MASI
Masimo Corp.
|
$175.10 | $178.60 | $9.4B | 116.80x | $0.00 | 0% | 5.53x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.28 | $5.50 | $37.8M | -- | $0.00 | 0% | 4.41x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ANGO
AngioDynamics, Inc.
|
6.27% | 0.932 | 2.29% | 1.22x |
|
ABT
Abbott Laboratories
|
21.33% | 0.141 | 6.97% | 1.05x |
|
BSX
Boston Scientific Corp.
|
33.07% | 0.200 | 8.46% | 0.94x |
|
ISRG
Intuitive Surgical, Inc.
|
0.95% | 0.941 | 0.08% | 3.73x |
|
MASI
Masimo Corp.
|
41.99% | 0.815 | 7.4% | 1.68x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -1.387 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ANGO
AngioDynamics, Inc.
|
$42.1M | -$2.5M | -14.66% | -15.21% | -3.14% | $3M |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
ISRG
Intuitive Surgical, Inc.
|
$1.9B | $864.3M | 16.53% | 16.59% | 30.16% | $730M |
|
MASI
Masimo Corp.
|
$230.6M | $83.7M | -11.41% | -19.18% | 22.53% | $49.7M |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
AngioDynamics, Inc. vs. Competitors
-
Which has Higher Returns ANGO or ABT?
Abbott Laboratories has a net margin of -7.99% compared to AngioDynamics, Inc.'s net margin of 15.71%. AngioDynamics, Inc.'s return on equity of -15.21% beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital ANGOAngioDynamics, Inc.53.05% -$0.15 $188.1M ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About ANGO or ABT?
AngioDynamics, Inc. has a consensus price target of $19.33, signalling upside risk potential of 72.31%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 18.88%. Given that AngioDynamics, Inc. has higher upside potential than Abbott Laboratories, analysts believe AngioDynamics, Inc. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings ANGOAngioDynamics, Inc.3 0 0 ABTAbbott Laboratories16 7 0 -
Is ANGO or ABT More Risky?
AngioDynamics, Inc. has a beta of 0.514, which suggesting that the stock is 48.595% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.138%.
-
Which is a Better Dividend Stock ANGO or ABT?
AngioDynamics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.14% to investors and pays a quarterly dividend of $0.63 per share. AngioDynamics, Inc. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ANGO or ABT?
AngioDynamics, Inc. quarterly revenues are $79.4M, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. AngioDynamics, Inc.'s net income of -$6.4M is lower than Abbott Laboratories's net income of $1.8B. Notably, AngioDynamics, Inc.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 30.19x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AngioDynamics, Inc. is 1.50x versus 4.43x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ANGOAngioDynamics, Inc.1.50x -- $79.4M -$6.4M ABTAbbott Laboratories4.43x 30.19x $11.5B $1.8B
-
Which has Higher Returns ANGO or BSX?
Boston Scientific Corp. has a net margin of -7.99% compared to AngioDynamics, Inc.'s net margin of 12.68%. AngioDynamics, Inc.'s return on equity of -15.21% beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital ANGOAngioDynamics, Inc.53.05% -$0.15 $188.1M BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About ANGO or BSX?
AngioDynamics, Inc. has a consensus price target of $19.33, signalling upside risk potential of 72.31%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.75 which suggests that it could grow by 40.45%. Given that AngioDynamics, Inc. has higher upside potential than Boston Scientific Corp., analysts believe AngioDynamics, Inc. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings ANGOAngioDynamics, Inc.3 0 0 BSXBoston Scientific Corp.25 0 0 -
Is ANGO or BSX More Risky?
AngioDynamics, Inc. has a beta of 0.514, which suggesting that the stock is 48.595% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.666, suggesting its less volatile than the S&P 500 by 33.441%.
-
Which is a Better Dividend Stock ANGO or BSX?
AngioDynamics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AngioDynamics, Inc. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ANGO or BSX?
AngioDynamics, Inc. quarterly revenues are $79.4M, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. AngioDynamics, Inc.'s net income of -$6.4M is lower than Boston Scientific Corp.'s net income of $670M. Notably, AngioDynamics, Inc.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 38.46x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AngioDynamics, Inc. is 1.50x versus 5.55x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ANGOAngioDynamics, Inc.1.50x -- $79.4M -$6.4M BSXBoston Scientific Corp.5.55x 38.46x $5.3B $670M
-
Which has Higher Returns ANGO or ISRG?
Intuitive Surgical, Inc. has a net margin of -7.99% compared to AngioDynamics, Inc.'s net margin of 27.89%. AngioDynamics, Inc.'s return on equity of -15.21% beat Intuitive Surgical, Inc.'s return on equity of 16.59%.
Company Gross Margin Earnings Per Share Invested Capital ANGOAngioDynamics, Inc.53.05% -$0.15 $188.1M ISRGIntuitive Surgical, Inc.66.41% $2.21 $18.1B -
What do Analysts Say About ANGO or ISRG?
AngioDynamics, Inc. has a consensus price target of $19.33, signalling upside risk potential of 72.31%. On the other hand Intuitive Surgical, Inc. has an analysts' consensus of $611.82 which suggests that it could grow by 21.38%. Given that AngioDynamics, Inc. has higher upside potential than Intuitive Surgical, Inc., analysts believe AngioDynamics, Inc. is more attractive than Intuitive Surgical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ANGOAngioDynamics, Inc.3 0 0 ISRGIntuitive Surgical, Inc.16 10 1 -
Is ANGO or ISRG More Risky?
AngioDynamics, Inc. has a beta of 0.514, which suggesting that the stock is 48.595% less volatile than S&P 500. In comparison Intuitive Surgical, Inc. has a beta of 1.653, suggesting its more volatile than the S&P 500 by 65.303%.
-
Which is a Better Dividend Stock ANGO or ISRG?
AngioDynamics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intuitive Surgical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AngioDynamics, Inc. pays -- of its earnings as a dividend. Intuitive Surgical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ANGO or ISRG?
AngioDynamics, Inc. quarterly revenues are $79.4M, which are smaller than Intuitive Surgical, Inc. quarterly revenues of $2.9B. AngioDynamics, Inc.'s net income of -$6.4M is lower than Intuitive Surgical, Inc.'s net income of $799.5M. Notably, AngioDynamics, Inc.'s price-to-earnings ratio is -- while Intuitive Surgical, Inc.'s PE ratio is 64.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AngioDynamics, Inc. is 1.50x versus 18.17x for Intuitive Surgical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ANGOAngioDynamics, Inc.1.50x -- $79.4M -$6.4M ISRGIntuitive Surgical, Inc.18.17x 64.00x $2.9B $799.5M
-
Which has Higher Returns ANGO or MASI?
Masimo Corp. has a net margin of -7.99% compared to AngioDynamics, Inc.'s net margin of 14.46%. AngioDynamics, Inc.'s return on equity of -15.21% beat Masimo Corp.'s return on equity of -19.18%.
Company Gross Margin Earnings Per Share Invested Capital ANGOAngioDynamics, Inc.53.05% -$0.15 $188.1M MASIMasimo Corp.62.07% -$1.86 $1.4B -
What do Analysts Say About ANGO or MASI?
AngioDynamics, Inc. has a consensus price target of $19.33, signalling upside risk potential of 72.31%. On the other hand Masimo Corp. has an analysts' consensus of $178.60 which suggests that it could grow by 2%. Given that AngioDynamics, Inc. has higher upside potential than Masimo Corp., analysts believe AngioDynamics, Inc. is more attractive than Masimo Corp..
Company Buy Ratings Hold Ratings Sell Ratings ANGOAngioDynamics, Inc.3 0 0 MASIMasimo Corp.0 7 0 -
Is ANGO or MASI More Risky?
AngioDynamics, Inc. has a beta of 0.514, which suggesting that the stock is 48.595% less volatile than S&P 500. In comparison Masimo Corp. has a beta of 1.262, suggesting its more volatile than the S&P 500 by 26.165%.
-
Which is a Better Dividend Stock ANGO or MASI?
AngioDynamics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Masimo Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AngioDynamics, Inc. pays -- of its earnings as a dividend. Masimo Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ANGO or MASI?
AngioDynamics, Inc. quarterly revenues are $79.4M, which are smaller than Masimo Corp. quarterly revenues of $371.5M. AngioDynamics, Inc.'s net income of -$6.4M is lower than Masimo Corp.'s net income of $53.7M. Notably, AngioDynamics, Inc.'s price-to-earnings ratio is -- while Masimo Corp.'s PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AngioDynamics, Inc. is 1.50x versus 5.53x for Masimo Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ANGOAngioDynamics, Inc.1.50x -- $79.4M -$6.4M MASIMasimo Corp.5.53x 116.80x $371.5M $53.7M
-
Which has Higher Returns ANGO or PSTV?
Plus Therapeutics, Inc. has a net margin of -7.99% compared to AngioDynamics, Inc.'s net margin of -316.61%. AngioDynamics, Inc.'s return on equity of -15.21% beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ANGOAngioDynamics, Inc.53.05% -$0.15 $188.1M PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About ANGO or PSTV?
AngioDynamics, Inc. has a consensus price target of $19.33, signalling upside risk potential of 72.31%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1900%. Given that Plus Therapeutics, Inc. has higher upside potential than AngioDynamics, Inc., analysts believe Plus Therapeutics, Inc. is more attractive than AngioDynamics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ANGOAngioDynamics, Inc.3 0 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is ANGO or PSTV More Risky?
AngioDynamics, Inc. has a beta of 0.514, which suggesting that the stock is 48.595% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.886, suggesting its less volatile than the S&P 500 by 11.364%.
-
Which is a Better Dividend Stock ANGO or PSTV?
AngioDynamics, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. AngioDynamics, Inc. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ANGO or PSTV?
AngioDynamics, Inc. quarterly revenues are $79.4M, which are larger than Plus Therapeutics, Inc. quarterly revenues of $1.4M. AngioDynamics, Inc.'s net income of -$6.4M is lower than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, AngioDynamics, Inc.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for AngioDynamics, Inc. is 1.50x versus 4.41x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ANGOAngioDynamics, Inc.1.50x -- $79.4M -$6.4M PSTVPlus Therapeutics, Inc.4.41x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 23
RingCentral, Inc. [RNG] is down 12.48% over the past day.
Sell
9
FROG alert for Feb 23
JFrog Ltd. [FROG] is down 7.95% over the past day.
Buy
72
SNSE alert for Feb 23
Sensei Biotherapeutics, Inc. [SNSE] is down 2.63% over the past day.
